Sunday 21 September 2014
 
»
Tag
 
»
Placebo

Sanofi says MS treatment reduced relapse rate

Sanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m

Moreā€¦
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads